reposted from: Podcast
http://media.newscientist.com/data/av/podcast/newsci-20070105-new-scientist-live.mp3
my highlights
Three renowned thinkers converge to discuss what the next 50 years will bring for physics, life sciences and the interaction of society with technology. This podcast includes excerpts from a special New Scientist Live programme hosted by the New York Academy of Sciences, featuring guest speakers EO Wilson, Sherry Turkle and Paul Davies.
EO Wilson on the Scientific Method
"the power of science does not so much come from scientists as from the method; the power of and the beaty the scientific method comes from its simplicity - the scientific method can be understood by anyone and pracitised with a modest amount of training; it stature arises from its cumulative nature - favoured sometimes by a unifying genius it is mostly the product of 100,000s of specialists united by the scientific method science has become the most democratic of all human endevours; science is not a religion; science is not an ideology, science makes no claims beyond what can be sensed in the real world; it generates knowledge in the most productive and unifying manner contrived in history - Science serves humanity without obesence to any particular tribal ideology."
Paul Davies
Astrobiology - is life easy to get started? Has life evolved more than once on Earth? Are their biomarkers from an alternative biological system right here on Earth in the rocks? Is alien life amongst us as microbes?
What will we learn in the next 50 years?
Origin of Universe by the scientific method (principles of physics); origin of mass; artificial life - life in the test tube; controlled fusion; colonise Mars; Dark Matter; Dark Energy; Origin of Life (are traces obliterated); nature of consciousness; End of the Universe; Multiverses; Ultimate structure of matter; quantum computation.
Monday, January 15, 2007
Celebrating New Scientist Magazine at 50 - Science in the next 50 years
Posted by crabsallover at Monday, January 15, 2007 0 comments
Labels: Biology, E O Wilson, Paul Davies, scientific method
Red Wine resveratrol extract has health benefits
my highlights / edits
Can I eat anything I want as long as I drink red wine?
A study published yesterday in the online version of the journal Nature has been called the "Holy Grail of aging research," and its results aren't even fully understood at this point. In the study, obese mice fed absurdly large amounts of red-wine extract developed none of the health problems normally associated with obesity.
The red-wine extract used in the study is called resveratrol. (source: wikipedia)
The lead researcher for the study, Dr. David Sinclair of Harvard Medical School, who also owns a pharmaceutical company working to develop and market a drug based on these results, had been looking for a compound that activated the "longevity gene" SIRT-1 (wikipedia). Science has known for decades that this gene responds to metabolic processes and seems to release a life-sustaining protein called sirtuin in response to a low-calorie diet. This effect is most likely an evolutionary development designed to keep people alive in times of famine so they could make it through the food shortage, start eating again, and reproduce. What Sinclair's group found was that resveratrol appears to activate SIRT-1, although some biochemists say the full chemical data to support that finding are absent from Sinclair's published article. What is pretty clear, however, is that resveratrol has dramatic effects when combined with a high-calorie diet.
|
The overfed mice who were also given high doses of resveratrol were fat, active and healthy, living as long as the mice in the "healthy weight" group and far longer than the mice in the overfed group who did not get the red-wine extract. Those mice developed insulin resistance (associated with diabetes in humans) and liver problems, were slow and inactive, and died young. In the overfed-plus-resveratrol group, the resveratrol appears to have negated all of the ill effects of overeating except for weight gain.
But don't run out and start adding red wine to your diet because of this study. First of all, like other supplements, what is good for you in small doses may be bad for you in large doses, and resveratrol has not been proven safe for humans in high doses. Also, while the protein sirtuin is believed to increase lifespan, it also has been shown to decrease fertility when activated by a restricted-calorie diet. If resveratrol is indeed mimicking the chemical effects of a calorie-restricted diet in order to activate SIRT-1, fertility issues are a potential side effect, although Sinclair found no evidence of decreased fertility in his study.
And there's one inescapable reason why you're going to have to wait a while before you can reap the benefits of this research: An adult would have to drink about 1,000 bottles of red wine a day to get the dose of resveratrol the mice got in the study. While small amounts of red wine have been shown to be good for the heart, it seems unlikely that humans could get the therapeutic effects of resveratrol observed in this study from drinking red wine. Sinclair's company, Sirtris Pharmaceuticals, is working to develop a chemical that mimics the effects of resveratrol but works in a lower dose. The company estimates about a five-year wait before this type of drug would be ready for FDA approval.
For more information on obesity and resveratrol, as well as related topics, check out the following links:
- PDR Health: Resveratrol
- Scientific American: The Fountain of Youth at the Bottom of a Wine Bottle? - Nov. 2, 2006
- WashingtonPost.com: Fat Found to Accelerate Aging Process - June 14, 2005
Sources
- "Study: Fat, boozing mice stay healthy." CNN.com. Nov. 1, 2006.
http://www.cnn.com/2006/HEALTH/conditions/11/01/fat.fightingwine.ap/index.html - Wade, Nicholas. "Yes, Red Wine Holds Answer. Check Dosage." The New York Times. Nov. 2, 2006
http://www.nytimes.com/2006/11/02/science/02drug.html?_r=1&ref=health&oref=login
Obesity-busting gum - 30,000 deaths a year are caused by obesity
my highlights / edits
Hope over 'obesity-busting gum'
One in five adults in the UK is obese |
The Imperial College London team are developing a drug based on a natural gut hormone that mimics the body's "feeling full" response.
An injectible treatment could be available in five to eight years, but the long-term goal is to produce a form that can be absorbed in the mouth.
One in five adults are obese, but that could rise to one in three by 2010.
The hormone in question is called pancreatic polypeptide (PP) (Wikipedia), which the body produces after every meal to ensure eating does not run out of control.
There is evidence that some people have more of the hormone than others, and becoming overweight reduces the levels produced.
A vicious circle then results, causing appetite to increase, an inability to resist the temptation of food, and further increases in weight.
Early tests have shown moderate doses of the hormone, pancreatic polypeptide (PP), can reduce the amount of food eaten by healthy volunteers by 15% to 20%.
The team have now been given funding of £2.2m from the Wellcome Trust to take it forward.
As well as chewing gum, they believe it could be incorporated in a nasal spray.
Problem
Lead researcher Professor Steve Bloom said: "We have got a problem and we don't know what to do about it.
"We hit on the idea of a chewing gum because obese people like chewing."
Professor Bloom's team first noted the effect of the hormone in a group of patients with a particular pancreatic tumour that causes them to generate more PP.
Their bodies were kept permanently thin for long periods of time, yet they appeared to suffer no ill effects from the hormone.
Professor Bloom's team has not yet been able to study obese patients, but has tested the hormone out on a small group of 35 mildly overweight but otherwise healthy volunteers.
Participants were given injections of either PP or an inactive salt solution without knowing what they were receiving.
They were then offered a large buffet meal and invited to eat as much as they liked.
At the same time they were asked to answer questions about how hungry they felt.
Those given the treatment felt less hungry and ate between 15% and 25% less - than those who received the placebo.
A real treatment would aim at cutting food intake by 5% to 10% initially, and thereafter maintain control over appetite with a small reduction of about 1%.
Dr Ted Bianco, of the Wellcome Trust, said: "Over 30,000 deaths a year are caused by obesity in England alone, so there is a clear need to develop a treatment to tackle this problem.
"Yet this need for effective anti-obesity therapies is currently unmet. We believe that Professor Bloom's research holds great promise and, with our support, can be translated into tangible benefits to health."
Diabetes UK care adviser Libby Dowling said: "Although trials have shown that this drug can help reduce appetite, it has only been trialled on people who already have a relatively healthy weight.
"We would continue to recommend eating a healthy diet and doing regular physical activity as the first and best step to losing weight."